LCTX: Lineage Cell Therapeutics, Inc. Stock

by  •  • Comments Off on LCTX: Lineage Cell Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 209.27
Enterprise Value ($M) 172.43
Book Value ($M) 62.02
Book Value / Share 0.33
Price / Book 3.37
NCAV ($M) -0.56
NCAV / Share -0.00
Price / NCAV -377.07

Profitability (mra)
Return on Invested Capital (ROIC) -0.33
Return on Assets (ROA) -0.19
Return on Equity (ROE) -0.31

Liquidity (mrq)
Quick Ratio 2.14
Current Ratio 2.14

Balance Sheet (mrq) ($M)
Current Assets 38.44
Assets 101.02
Liabilities 39.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 8.95
Operating Income -24.73
Net Income -21.49
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -28.57
Cash from Investing 46.45
Cash from Financing 6.42

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-08 13D/A Broadwood Partners, L.p. 22.20 19.18

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-07 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 86,665 313,340 27.66
2024-04-25 56,214 359,695 15.63
2024-04-24 103,252 747,332 13.82
2024-04-23 63,208 333,219 18.97

(click for more detail)

Similar Companies
CYBN – Cybin Inc. IBIO – iBio, Inc.
IGC – IGC Pharma, Inc. MAIA – MAIA Biotechnology, Inc.
MTNB – Matinas BioPharma Holdings, Inc.


Financial data and stock pages provided by
Fintel.io